Neon Therapeutics Inc (NTGN):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C8152)
◆英語タイトル:Neon Therapeutics Inc (NTGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8152
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:42
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Neon Therapeutics Inc (Neon Therapeutics) is a clinical-stage immuno-oncology company that focuses on the development of neoantigen-based therapeutics for the treatment of cancer. The company pipeline product portfolio comprises NEO-PV-01, a personal neoantigen vaccine; NEO-PTC-01, a personal neoantigen T cell therapy; and NEO-SV-01, a breast neoantigen vaccine among others. Neon Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Neon Therapeutics Inc (NTGN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Neon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Neon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Neon Therapeutics Raises Additional USD36 Million in Series B Financing 13
Neon Therapeutics Raises USD70 Million in Series B Financing 15
Neon Therapeutics Raises USD55 Million in Series A Venture Financing 17
Partnerships 18
Natera Enters into Research Agreement with Neon Therapeutics 18
Neon Therapeutics Enters into Agreement with Merck 19
Neon Therapeutics Enters into Agreement with Apexigen 20
CRISPR Therapeutics and Neon Therapeutics Enter into Research Agreement 21
Vedantra Pharma Extends Research Agreement with Neon Therapeutics 22
Neon Therapeutics Enters into Research Agreement with Netherlands Cancer Institute 23
Neon Therapeutics Enters into Agreement with Bristol-Myers Squibb 24
Licensing Agreements 25
Neon Therapeutics Enters into Licensing Agreement with Netherlands Cancer Institute 25
Neon Therapeutics Enters into Licensing Agreement with Sanquin Blood Supply Foundation 26
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 27
Equity Offering 28
Neon Therapeutics Raises USD100 Million in IPO of Shares 28
Neon Therapeutics Inc – Key Competitors 30
Neon Therapeutics Inc – Key Employees 31
Neon Therapeutics Inc – Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Financial Announcements 33
Aug 06, 2018: Neon Therapeutics reports second quarter 2018 financial results and recent business highlights 33
Corporate Communications 35
Dec 12, 2017: Neon Therapeutics Expands Board of Directors with Leading Experts in Cancer Drug Discovery and Corporate Finance 35
Jun 16, 2017: Dr. Yasir Al-Wakeel Joins Neon Therapeutics as Chief Financial Officer 36
Product News 37
Jul 05, 2017: Initial Results from Dana-Farber Cancer Institute Personalized Neoantigen Vaccine Published in Nature 37
07/05/2017: Personal neoantigen vaccine prompts strong anti-tumor response in patients, study showsx 38
Feb 21, 2017: Using Mono-Allelic Mass Spectrometry Data to Improve Epitope Prediction Algorithms Published in Immunity 40
Clinical Trials 41
May 08, 2018: Neon Therapeutics Announces First Patient Treated in Clinical Trial Evaluating Personal Cancer Vaccine NEO-PV-01 in Combination with KEYTRUDA (pembrolizumab) and Chemotherapy 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Neon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Neon Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Neon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Neon Therapeutics Raises Additional USD36 Million in Series B Financing 13
Neon Therapeutics Raises USD70 Million in Series B Financing 15
Neon Therapeutics Raises USD55 Million in Series A Venture Financing 17
Natera Enters into Research Agreement with Neon Therapeutics 18
Neon Therapeutics Enters into Agreement with Merck 19
Neon Therapeutics Enters into Agreement with Apexigen 20
CRISPR Therapeutics and Neon Therapeutics Enter into Research Agreement 21
Vedantra Pharma Extends Research Agreement with Neon Therapeutics 22
Neon Therapeutics Enters into Research Agreement with Netherlands Cancer Institute 23
Neon Therapeutics Enters into Agreement with Bristol-Myers Squibb 24
Neon Therapeutics Enters into Licensing Agreement with Netherlands Cancer Institute 25
Neon Therapeutics Enters into Licensing Agreement with Sanquin Blood Supply Foundation 26
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 27
Neon Therapeutics Raises USD100 Million in IPO of Shares 28
Neon Therapeutics Inc, Key Competitors 30
Neon Therapeutics Inc, Key Employees 31

List of Figures
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Neon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Neon Therapeutics Inc (NTGN):製薬・医療:M&Aディール及び事業提携情報(Neon Therapeutics Inc (NTGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆